These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38290477)

  • 1. Attitudes towards COVID-19 vaccination in adults with haematological malignancies.
    Blennerhassett R; Hamad N; Grech L; Kwok A; Choi T; Forsyth C; Jagger J; Opat S; Harris S; Chan BA; Nguyen M; Bain N; Day D; Segelov E;
    Acta Haematol; 2024 Jan; ():. PubMed ID: 38290477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers.
    Bain N; Nguyen M; Grech L; Day D; McCartney A; Webber K; Kwok A; Harris S; Chau H; Chan B; Nott L; Hamad N; Tognela A; Underhill C; Loe BS; Freeman D; Segelov E; On Behalf Of The Canvaccs Investigators
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia.
    Wang H; Grech L; Wong J; Hoffman D; de Courten B; Sillars B; Savage M; Kwok A; Nguyen M; Bain N; Day D; Segelov E; On Behalf Of The Diabvaccs Investigators
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932391
    [No Abstract]   [Full Text] [Related]  

  • 4. Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia.
    Day D; Grech L; Nguyen M; Bain N; Kwok A; Harris S; Chau H; Chan B; Blennerhassett R; Nott L; Hamad N; Tognela A; Hoffman D; McCartney A; Webber K; Wong J; Underhill C; Sillars B; Winkel A; Savage M; Loe BS; Freeman D; Segelov E; On Behalf Of The Canvaccs Diabvaccs And Msvaccs Investigators
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis.
    Grech L; Kwok A; Nguyen M; Winkel A; Butler E; Allan M; Bain N; Segelov E; On Behalf Of The Msvaccs Investigators
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Disease Influenced Vaccine Acceptance Scale-Six (DIVAS-6): Validation of a Measure to Assess Disease-Related COVID-19 Vaccine Attitudes and Concerns.
    Grech L; Loe BS; Day D; Freeman D; Kwok A; Nguyen M; Bain N; Segelov E
    Behav Med; 2023; 49(4):402-411. PubMed ID: 35703037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study.
    Nguyen M; Bain N; Grech L; Choi T; Harris S; Chau H; Freeman D; Kwok A; Williams J; McCartney A; Webber K; Day D; Segelov E
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):570-577. PubMed ID: 35043559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unpacking COVID-19 Vaccine Attitudes: Exploring Hesitancy and Acceptance Among Undergraduate Students in Bangladesh.
    Bhadra A; Podder V; Islam MM; Devnath S; Hafiz I; Chowdhury KJ; Sujon H; Islam MR; Ali FM; Odo TI; Sudrul M; Roy S; Dey A; Hossain F; Kirshan Kumar S; Agarwala A; Kakoly NS
    Cureus; 2023 Nov; 15(11):e49576. PubMed ID: 38156187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study.
    Huang Y; Zhang L; Fu J; Wu Y; Wang H; Xiao W; Xin Y; Dai Z; Si M; Chen X; Jia M; Leng Z; Cui D; Su X
    JMIR Public Health Surveill; 2023 Jul; 9():e42958. PubMed ID: 37247615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis.
    Panisset MG; Kilpatrick T; Cofré Lizama LE; Galea MP
    Mult Scler Relat Disord; 2022 Jul; 63():103933. PubMed ID: 35671672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. South African University Staff and Students' Perspectives, Preferences, and Drivers of Hesitancy Regarding COVID-19 Vaccines: A Multi-Methods Study.
    George G; Strauss M; Lansdell E; Nadesan-Reddy N; Moroe N; Reddy T; Eshun-Wilsonova I; Moshabela M
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding COVID-19 Vaccine Uptake and Hesitancy Among People With HIV in Freetown, Sierra Leone: A Cross-sectional Study.
    Cummings PE; Lakoh S; Yendewa SA; Massaquoi SPE; James PB; Sahr F; Deen GF; Gevao P; Yendewa GA
    medRxiv; 2023 May; ():. PubMed ID: 37292603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.
    Datar RS; Fette LM; Hinkelman AN; Hammershaimb EA; Friedman-Klabanoff DJ; Mongraw-Chaffin M; Weintraub WS; Ahmed N; Gibbs MA; Runyon MS; Plumb ID; Thompson W; Saydah S; Edelstein SL; Berry AA;
    Vaccine; 2023 May; 41(20):3204-3214. PubMed ID: 37069033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
    Steinmetz L
    BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    Sheikh NS; Touseef M; Sultan R; Cheema KH; Cheema SS; Sarwar A; Siddique HZ
    PLoS One; 2023; 18(8):e0289678. PubMed ID: 37585457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: results of a self-reporting questionnaire.
    Vagts C; Sweis JJG; Sweis NWG; Ascoli C; Rottoli P; Martone FM; Wells AU; Judson MA; Sweiss NJ; Lower EE; Baughman RP
    Sarcoidosis Vasc Diffuse Lung Dis; 2023 Jun; 40(2):e2023012. PubMed ID: 37382069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults.
    Omar DI; Hani BM
    J Infect Public Health; 2021 Oct; 14(10):1481-1488. PubMed ID: 34247946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey.
    Kwok KO; Li KK; Wei WI; Tang A; Wong SYS; Lee SS
    Int J Nurs Stud; 2021 Feb; 114():103854. PubMed ID: 33326864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.